Effectiveness of a Sample Pooling Strategy to Detect SARS-CoV-2, Thimphu, Bhutan, January–February 2021
DOI:
https://doi.org/10.59096/osir.v17i4.268747Keywords:
COVID-19, SARS-CoV-2, pooling, cycle threshold, RT-PCRAbstract
This retrospective study aimed to evaluate the effectiveness of a pooling strategy to detect SARS-CoV-2 by comparing cycle threshold (Ct) values of pooled samples and deconvoluted samples, and its cost savings. We evaluated 2,687 pools of 5 samples (n=13,435) and 5,444 pools of 10 samples (n=54,440). Of these, 51 and 40 pools were positive from the 5- and 10-sample pools, respectively. We analyzed the Ct values of positive samples obtained through pooled testing and compared them to the Ct values of their corresponding individual positive samples. We observed a decrease in the mean Ct value by 2.0 for the 5-sample pools and by 3.6 for the 10-sample pools when the pooled samples were deconvoluted and individually tested. The drop in the mean Ct value was more pronounced in samples with a low viral load. Where the known positive COVID-19 prevalence rate was 0.13%, the pooling strategy resulted in significant savings of 89.26% for pools of 10 samples and 78.10% for pools of 5 samples when compared to individual testing. Employing this pooling approach led to substantial savings in resources and time when conducting mass screening.
References
Tamang ST, Lhendup K, Dorji T. Control of travel-related COVID-19 in Bhutan. J Travel Med. 2021 Oct 11;28(7):taab137. doi:10.1093/jtm/taab137.
UN News. Testing, tracing, and when to lift restrictions: WHO’s latest advice [Internet]. New York: United Nations; 2020 Apr 13 [cited 2020 Jul 20]. <https://news.un.org/en/story/2020/04/1061642>
Emmanuel JC, Bassett MT, Smith HJ, Jacobs JA. Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries. J Clin Pathol. 1988 May;41(5):582–5. doi: 10.1136/jcp.41.5.582.
Van TT, Miller J, Warshauer DM, Reisdorf E, Jernigan D, Humes R, et al. Pooling nasopharyngeal/throat swab specimens to increase testing capacity for influenza viruses by PCR. J Clin Microbiol. 2012 Mar;50(3):891–6. doi:10.1128/JCM.05631-11.
Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, et al. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods. 2003;112(1–2):145–51. doi:10.1016/s0166-0934(03)00215-5.
Dorfman R. The detection of defective members of large populations. The Annals of Mathematical Statistics. 1943;14(4):436–40. doi:10.1214/aoms/1177731363.
Sharma G. Bhutan orders first coronavirus lockdown as cases hit 113 [Internet]. Eagan (MN): Reuters; 2020 Aug 11 [cited 2024 Sep 6]. <https://www.reuters.com/article/business/healthcare-pharmaceuticals/bhutan-orders-first-coronavirus-lockdown-as-cases-hit-113-idUSKCN2570TZ/>
Barathidasan R, Sharmila FM, Raj RV, Dhanalakshmi G, Anitha G, Dhodapkar R. Pooled sample testing for COVID-19 diagnosis: Evaluation of bi-directional matrix pooling strategies. J Virol Methods. 2022 Jun;304:114524. doi:10.1016/j.jviromet.2022.
Praharaj I, Jain A, Singh M, Balakrishnan A, Dhodapkar R, Borkakoty B, et al. Pooled testing for COVID-19 diagnosis by real-time RT-PCR: a multi-site comparative evaluation of 5- & 10-sample pooling. Indian J Med Res. 202;152(1–2):88–94. doi:10.4103/ijmr.IJMR_2304_20.
Mulu A, Alemayehu DH, Alemu F, Tefera DA, Wolde S, Aseffa G, et al. Evaluation of sample pooling for screening of SARS CoV-2. PLoS One. 2021 Feb 26;16(2):e0247767. doi:10.1371/journal.pone.0247767.
de Salazar A, Aguilera A, Trastoy R, Fuentes A, Alados JC, Causse M, et al. Sample pooling for SARS-CoV-2 RT-PCR screening. Clin Microbiol Infect. 2020 Dec;26(12):1687.e1–1687.e5. doi:10.1016/j.cmi.2020.09.008.
Bautista LE, Villar LA, Cleves MA, Gelvez M, Lozano-Parra A, Bueno-Ariza N, et al. Sensitivity and efficiency of RNA sample pooling for real-time quantitative polymerase chain reaction testing for SARS-CoV-2. J Public Health Emerg. 2022;6:12. doi:10.21037/jphe-21-97.
Mahmoud SA, Ibrahim E, Thakre B, Teddy JG, Raheja P, Ganesan S, et al. Evaluation of pooling of samples for testing SARS-CoV- 2 for mass screening of COVID-19. BMC Infect Dis. 2021 Apr 17;21(1):360. doi:10.1186/s12879-021-06061-3.
Verdun CM, Fuchs T, Harar P, Elbrachter D, Fischer DS, Berner J, et al. Group testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategies. Front Public Health. 2021 Aug 18;9:583377. doi:10.3389/fpubh.2021.583377.
Gupta E, Padhi A, Khodare A, Agarwal R, Ramachandran K, Mehta V, et al. Pooled RNA sample reverse transcriptase real time PCR assay for SARS CoV-2 infection: A reliable, faster and economical method. PLoS One. 2020 Jul 30;15(7):e0236859. doi:10.1371/journal.pone.0236859.
Abdelrazik AM, Said MN El, Abdelaziz HM. Evaluation of pooling strategy of SARS-CoV-2 RT-PCR in limited resources setting in Egypt at low prevalence. Comp Clin Path. 2023;32(3):375–81. doi:10.1007/s00580-023-03445-6.
Abdalhamid B, Bilder CR, Garrett JL, Iwen PC. Cost effectiveness of sample pooling to test for SARS-CoV-2. J Infect Dev Ctries. 2020 Oct 31;14(10):1136–7. doi:10.3855/jidc.13935.
Kim EY, Kim J, Sung H, Jo MW. Cost analysis of coronavirus disease 2019 test strategies using pooled reverse transcriptase-polymerase chain reaction technique. J Clin Lab Anal. 2022 May;36(5):e24413. doi:10.1002/jcla.24413.
Lim KL, Johari NA, Wong ST, Khaw LT, Tan BK, Chan KK, et al. A novel strategy for community screening of SARS-CoV-2 (COVID-19): Sample pooling method. PLoS One. 2020 Aug 28;15(8):e0238417. doi:10.1371/journal.pone.0238417.
Sitko JC, Steel JJ, Almand EA, Cullenbine CA, Rohrer JW, Wickert DP, et al. Efficiency of pooled surveillance testing in academic labs to detect and inhibit COVID-19 outbreaks. Bioanalysis. 2021 Aug;13(15):1177–82. doi:10.4155/bio-2021-0054.
Mandhan P, Sharma M, Pandey S, Chandel N, Chourasia N, Moun A, et al. A regionalpp intervention in a high-throughput COVID-19 diagnostic laboratory to enhance throughput, save resources and time over a period of 6 months. Front Microbiol. 2022 Jun 9;13:858555. doi:10.3389/fmicb.2022.858555.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Outbreak, Surveillance, Investigation & Response (OSIR) Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
